HPV vaccine response study for people living with HIV
Treatments studied
Part of Cancer, Immune system & allergy, Infections, Women’s health & pregnancy clinical trials.
This trial studies how well the Gardasil-9 HPV vaccine triggers the body’s immune response in people living with HIV. It may help doctors understand the best way to protect against HPV-related cancers and infections in this population.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have HIV.
- Your recent CD4 count (a type of immune cell) is above 200.
- Your recent HIV viral load is controlled and below 1,000 copies.
- You have been on the same HIV medicines (antiretroviral regimen) for at least 3 months.
- You are either vaccine-naive and age 45 or younger, or you already completed 3 doses of Gardasil-4 or Gardasil-9.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a lower dose of the HPV vaccine can still be effective and safe for women living with HIV. It may be helpful if you need HPV protection and the study’s dose schedule could reduce vaccine burden.
This study tests how well the Gardasil 9 HPV vaccine works in people assigned male at birth, including those with HIV and those taking hormone therapy. Results could help protect against HPV-related cancers.
This trial tests an HPV vaccine in people living with HIV to see if it is safe and helps their immune system fight HPV. HPV can cause certain cancers, and this study hopes to protect people with HIV who are more at risk.
This study looks at how well the HPV vaccine works in women who have already been exposed to the virus through sexual activity. It aims to understand the immune response and potentially improve protection against HPV-related cancers.
This study looks at how well the HPV vaccine works in women living with HIV and whether it helps make cervical cancer screening more accurate. If you are a woman with HIV between 21 and 40 years old and already part of certain other HIV studies, you may be able to join.
This study looks at whether getting the HPV vaccine along with regular cervical cancer screening (using an HPV test) can help prevent cervical cancer in women living with HIV. It is designed to be done as part of your usual HIV clinic visits, making it easier for you to take part.
Hear when a new Papillomavirus Vaccines trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.